Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stem Vida International is a biotechnology company and medical provider specializing in advanced regenerative medicine and stem cell therapies. Based in Mexico, the company focuses on the clinical application of mesenchymal stem cells (MSCs) derived from various sources, including umbilical cord tissue, to treat a wide range of chronic and degenerative conditions. Their services encompass treatments for autoimmune disorders, orthopedic injuries, and metabolic diseases, as well as wellness and anti-aging protocols. Stem Vida operates specialized clinics that integrate laboratory research with direct patient care to provide personalized regenerative solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stem Vida International.